How can ophthalmologists better educate patients about the severity of DME progression?
Merck completes acquisition of EyeBio
Study suggests potential link between semaglutide and risk of non-arteritic ischemic optic neuropathy
YOSEMITE/RHINE post-hoc analyses: Faricimab achieved similar visual and anatomic results to aflibercept in patients with 20/50 or worse vision
ANI Pharmaceuticals to expand footprint into ophthalmology with acquisition of Alimera Sciences
Enhancing patient outcomes
Diabetes drug suppresses retinal angiogenesis in mice